Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

被引:9
|
作者
Heitel, Pascal [1 ,2 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England
[2] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany
来源
MOLECULES | 2023年 / 28卷 / 02期
关键词
heterobifunctional molecules; proximity-inducing chimeras; targeted protein modification; conditional protein degradation; INDUCED DEGRADATION; DRUG DISCOVERY; RECEPTOR; KNOCKDOWN; RECOGNITION; THERAPY; LIGANDS; PROTACS; TAG;
D O I
10.3390/molecules28020690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Posttranslational modifications (PTMs) play an important role in cell signaling and they are often deregulated in disease. This review addresses recent advances in the development of heterobifunctional small molecules that enable targeting or hijacking PTMs. This emerging field is spearheaded by proteolysis-targeting chimeras (PROTACs), that induce ubiquitination of their targets and, thus, tag them for degradation by the proteasome. Within the last decade, several improvements have been made to enhance spatiotemporal control of PROTAC-induced degradation as well as cell permeability. Inspired by the success story of PROTACs, additional concepts based on chimeric small molecules have emerged such as phosphatase-recruiting chimeras (PhoRCs). Herein, an overview of strategies causing (de-)phosphorylation, deubiquitination as well as acetylation is provided, and the opportunities and challenges of heterobifunctional molecules for drug discovery are highlighted. Although significant progress has been achieved, a plethora of PTMs have not yet been covered and PTM-inducing chimeras will be helpful tools for chemical biology and could even find application in pharmacotherapy.
引用
收藏
页数:28
相关论文
共 50 条
  • [31] Unraveling the Roles of Protein Kinases in Autophagy: An Updateon Small-Molecule Compounds for Targeted Therapy
    Fu, Jiahui
    Yang, Yushang
    Zhu, Lingjuan
    Chen, Yi
    Liu, Bo
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (08) : 5870 - 5885
  • [32] Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders
    Hu, Jianping
    Wei, Jieli
    Yim, Hyerin
    Wang, Li
    Xie, Ling
    Jin, Margaret S.
    Kabir, Md
    Qin, Lihuai
    Chen, Xian
    Liu, Jing
    Jin, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15883 - 15905
  • [33] Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation Miniperspective
    Xie, Shaowen
    Zhu, Jingjie
    Li, Junda
    Zhan, Feiyan
    Yao, Hong
    Xu, Jinyi
    Xu, Shengtao
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 10917 - 10933
  • [34] Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors
    Sawyer, TK
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (01) : 1 - 19
  • [35] Small-molecule dual inhibitors targeting heat shock protein 90 for cancer targeted therapy
    Xie, Xin
    Zhang, Nan
    Li, Xiang
    Huang, He
    Peng, Cheng
    Huang, Wei
    Foster, Leonard J.
    He, Gu
    Han, Bo
    BIOORGANIC CHEMISTRY, 2023, 139
  • [36] Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
    Guo, Renyu
    Yang, Fukang
    Cherney, Emily C.
    RSC MEDICINAL CHEMISTRY, 2025,
  • [37] Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development
    Tan, Xueqiang
    Huang, Zuyi
    Pei, Hairun
    Jia, Zongchao
    Zheng, Jimin
    ISCIENCE, 2024, 27 (09)
  • [38] Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B
    Sarmiento, M
    Wu, L
    Keng, YF
    Song, L
    Luo, ZW
    Huang, ZW
    Wu, GZ
    Yuan, AK
    Zhang, ZY
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (02) : 146 - 155
  • [39] C-terminal binding protein (CtBP): An emerging oncogene and small molecule drug target in solid tumors
    Sumner, Evan T.
    Korwar, Sudha
    Morris, Benjamin L.
    Dcona, Martin M.
    Hilbert, Brendan J.
    Royer, William E.
    Ellis, Keith C.
    Grossman, Steven
    CANCER RESEARCH, 2016, 76
  • [40] The biological evaluation of small molecule inducers of Nrf2 transcriptional activity that inhibit the Keap1-Nrf2 protein-protein interaction.
    Fowkes, Adrian
    Schaap, Marjolein
    Bertrand, Helene
    Thiollier, Clarisse
    Kaatchi, Hiroko
    Wells, Geoff
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)